| Stage | DOCS | % of rev | VRSN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $157M | 100.00% | $443M | 100.00% | VRSN ×2.83 |
| Gross profit | $133M | 84.87% | $393M | 88.76% | VRSN +3.9pp |
| Operating income | $34M | 21.48% | $297M | 66.93% | VRSN +45.4pp |
| Pre-tax income | $40M | 25.77% | $280M | 63.12% | VRSN +37.3pp |
| Net income | $24M | 15.53% | $213M | 47.99% | VRSN +32.5pp |
| Stage | DOCS | VRSN | Gap · A − B |
|---|---|---|---|
| Revenue | $157M100.00% | $443M100.00% | VRSN ×2.83 |
| Gross profit | 84.87%$133M | 88.76%$393M | VRSN +3.9pp |
| Operating income | 21.48%$34M | 66.93%$297M | VRSN +45.4pp |
| Pre-tax income | 25.77%$40M | 63.12%$280M | VRSN +37.3pp |
| Net income |
| 15.53%$24M |
| 47.99%$213M |
| VRSN +32.5pp |